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Determines JNK Action
The intricate interplay between NF-kB and JNK deter-
mines TNF-a cytotoxicity. In a recent Cell paper,
Chang et al. (2006) report that prolonged JNK1 activa-
tion promotes TNF-a killing via E3 ligase-mediated
degradation of the caspase 8 inhibitor cFLIPL. On
the other hand, Ventura et al. (2006) show in their re-
centMolecular Cell paper that transient JNK activation
suppresses TNF-a-induced cell death.
The proinflammatory cytokine tumor necrosis factor
(TNF-a) regulates a variety of biological activities, in-
cluding immune responses, inflammation, proliferation,
and programmed cell death. TNF-a exerts its biological
functions via activation of multiple downstream effec-
tors, such as NF-kB, JNK, and caspases. TNF-a acti-
vates NF-kB and JNK via the signaling Complex I, which
is composed of TNFR1, TRADD, TRAF2, RIP1, cIAP1
and cIAP2. TNF-a is also able to activate the cell death
pathway through the signaling Complex II, which con-
sists of TRADD, TRAF2, RIP1, FADD, and caspase 8.
Yet, TNF-a does not typically induce cell death unless
NF-kB activation is blocked. This is because NF-kB in-
duces expression of various inhibitors of apoptosis
including cFLIPL, which specifically inhibits the key ini-
tiation caspase 8 and thereby blocks TNF-a-induced
programmed cell death.
For a long time, the role of JNK activation in TNF-a-
induced cell death has been highly controversial (Lin,
2003). Recent studies demonstrate that in addition to in-
hibition of caspases, NF-kB inhibits JNK activation to
suppress TNF-a-induced cell death. In the presence of
simultaneous activation of NF-kB, TNF-a induces tran-
sient JNK activation. When NF-kB activation is abro-
gated, TNF-a induces prolonged JNK activation, which
is required for TNF-a-induced cell death (De Smaele
et al., 2001; Tang et al., 2001). NF-kB inhibits JNK acti-
vation via several mechanisms, including the induction
of antioxidants that prevent the oxidation-mediated
inhibition of MAPK phosphatases by reactive oxygen
species (ROS) (Kamata et al., 2004). The negative regu-
lation of JNK activation by NF-kB for cell survival ap-
pears to be TNF-a specific, as NF-kB does not affect
IL-1-induced JNK activation (Tang et al., 2001; Chang
et al., 2006), or even positively regulates UV-induced
JNK activation for cell death (Liu et al., 2006).
Despite its ability to promote TNF-a-induced cell
death, prolonged JNK1 activation is insufficient to in-
duce cell death even in the absence of NF-kB activation
(Tang et al., 2001; Chang et al., 2006). Thus, it has been
hypothesized that TNF-a-induced prolonged JNK1 acti-
vation may eliminate inhibitors of apoptosis to promote,
but not initiate, cell death, i.e., ‘‘breaking the brake on
apoptosis’’ (Lin, 2003). Chang et al. (2006) convincinglyshow that in the presence of the protein synthesis inhib-
itor cycloheximide or the superrepressor IkBa-SR, both
of which inhibit the antiapoptotic functions of NF-kB,
TNF-a induces proteosome-mediated degradation of
cFLIPL and subsequent apoptosis in wild-type, but not
Jnk12/2 hepatocytes. The authors elegantly demon-
strate that the link between prolonged JNK1 activation
and proteosome-mediated degradation of cFLIPL is
the E3 ligase Itch, a newly identified JNK1 substrate
(Gao et al., 2004). According to the model proposed
by the authors, prolonged JNK1 activation promotes
cell death by targeting the same caspase 8 inhibitor
cFLIPL that is induced by NF-kB for cell survival. Phos-
phorylation and activation of Itch by JNK1 is required for
selective ubiquitination of cFLIPL, a requisite for its deg-
radation by the proteosome. The authors suggest that
prolonged, but not transient, JNK1 activation is required
for sustained activation of Itch so that cFILPL can be
fully eliminated by the proteosome. Furthermore, the
authors provide strong evidence that the JNK1-Itch-
cFLIPL pathway promotes TNF-a-induced toxicity in
two mouse model systems, i.e., Con-A- or LPS/GlaN-
induced acute liver failure. Since liver hepatocytes are
one of the major targets of TNF-a-induced cell death
in vivo, the finding by Chang et al. provides a novel
mechanism by which prolonged JNK1 activation pro-
motes TNF-a killing in a pathophysiological setting.
Unlike the well-known proapoptotic function of pro-
longed JNK1 activation in TNF-a-induced cell death,
the role of transient JNK activation is less understood.
Earlier studies show that JNK suppresses TNF-a-
induced apoptosis through activation of JunD, which
collaborates with NF-kB to induce anti-apoptotic genes
expression (Lamb et al., 2003). Ventura et al. (2006) ele-
gantly generate a JNK mutant with the approach of
chemical genetics. The JNK mutant has an enlarged
ATP binding pocket so it can be selectively inhibited
by 1NM-PP1, a bulk inhibitor that can fit into the en-
larged ATP binding pocket to compete with ATP. Using
primary Jnk12/2Jnk22/2 murine embryonic fibroblasts
(MEFs) expressing the JNK mutant as a model system,
the authors provide strong evidence that in the pres-
ence of NF-kB activation, both transient early phase
and sustained late phase of JNK activation contribute
to TNF-a-induced gene expression. The sustained late
phase JNK activation is very weak and is different
from the prolonged strong JNK activation when NF-kB
activation is blocked. The authors clearly show that
when NF-kB activation is abrogated, addition of INM-
PP1 prior to TNF-a stimulation, which abolishes both
transient and prolonged JNK activation, enhances cell
death. By contrast, addition of INM-PP1 after TNF-
a stimulation, which only inhibits the prolonged JNK ac-
tivation, suppresses cell death. The authors suggest
that in primary MEFs, transient JNK activation inhibits
TNF-a-induced cell death, whereas prolonged JNK acti-
vation promotes TNF-a killing. According to the model
proposed by the authors, transient JNK activation is re-
quired for TNF-a-induced expression of antiapoptotic
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278genes, including the ubiquitin ligase cIAP2. These re-
sults provide an important step toward understanding
how the timing plays a part in the functional output of
JNK activation.
While the findings by Chang et al. (2006) and Ventura
et al. (2006) provide insight into the molecular mecha-
nism by which JNK regulates TNF-a-induced cell death,
many questions still remain to be answered. How is the
inactivation of JNK1-activated Itch regulated? Is there
any other Itch target in the TNF-a-induced death path-
way? How does prolonged JNK1 promote TNF-a-
induced cell death in cells where cFLIPL may not be
the major inhibitor of caspase 8? What is the relation be-
tween Itch-triggered and caspase 8-mediated degrada-
tion of cFLIPL? Does transient JNK activation inhibit
TNF-a-induced cell death in a pathophysiological set-
ting? Is transient JNK activation required for suppres-
sion of TNF-a-induced cell death in other cell types?
How important is the induction of cIAP2 in mediating
the antiapoptotic function of transient JNK activation?
Since JNK is a potential therapeutic target for various
human diseases and cancer, future studies that uncover
the molecular mechanisms underlying the functions of
JNK will not only shed light on the JNK biology, but
may also provide novel strategies in disease prevention
and treatment.Developmental Cell 10, March, 2006 ª2006 Elsevier Inc. DOI 10.1016/j
No ESCRT to the Melanosome:
MVB Sorting without Ubiquitin
Multivesicular bodies (MVBs) are critical for a variety
of cellular functions ranging from lysosomal degrada-
tion to the budding of HIV. To date, delivery into MVBs
has been dependent on the ESCRT machinery. How-
ever, analysis of a melanosomal protein has uncov-
ered an alternative pathway for MVB sorting.
The delivery of transmembrane precursors and recep-
tors into the lumen of lysosome and lysosome-related
organelles requires the sorting of these proteins into in-
tralumenal vesicles (ILV) in an endosomal compartment,
giving rise to the multivesicular endosome or body (MVE
or MVB). However, the mechanism of discrete sorting of
ILV cargoes between the lysosome and nondegradative
lysosome-related organelles, such as the melanosome,
has been a mystery. Theos et al. (2006) have now shed
light on this problem through identifying the ILV sorting
determinants of the melanosomal protein Pmel17. In
contrast to the previously characterized cytoplasmic
ubiquitin signal that directs sorting into MVBs destined
for the lysosome, the sorting of Pmel17 occurs through
a lumenal signal that is independent of the ESCRT (en-Anning Lin
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dosomal sorting complex required for transport) ma-
chinery. These findings establish a novel paradigm for
sorting into MVBs.
The endosomal system is a dynamic site of protein
sorting that coordinates protein trafficking between
the Golgi, plasma membrane, lysosome, and special-
ized lysosome-related organelles including melano-
somes. Endosomal cargoes must be directed to these
subcellular compartments for a variety of purposes in-
cluding recycling, degradation, or biological function.
An elaborate system of cis- and trans-acting factors en-
sure that these sorting reactions are executed properly,
as aberrant sorting can negatively impact a variety of
cellular functions. For example, inappropriate lyso-
somal degradation of cell surface receptors prevents
appropriate environmental sensing and uptake of nutri-
ents. An additional level of endosomal sorting occurs
through the formation of MVBs. MVB formation occurs
when selected lipid and protein cargoes are actively
partitioned into membrane domains that will invaginate
and bud into the lumen of the endosome, giving rise to
its characteristic ‘‘multivesicular’’ appearance. MVB for-
mation is critical for a variety of cellular functions includ-
ing protein degradation via the lysosome, but also non-
degradative functions including exosome release,
formation of lysosome-related organelles, and retroviral
budding.
